Our analysis of the autoantibody profile in sarcoidosis patients, recruited as part of the GRADS study, revealed the presence of increased autoantibody levels in both pulmonary-only and extra-pulmonary cohorts compared to healthy controls for both the IgM and IgG. Here, CD40LG is linked to sarcoidosis.